Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |